Security Check
Dr. Xue-Ning Yang

Dr. Xue-Ning Yang, MD

Senior Consultant
Code: 110440000001971
Lung Cancer Surgery Evidence-Based Oncology Clinical Trials MDT Leader
Experience20+ years
LanguagesEnglish | 中文
Typical turnaround3–5 business days
Second-opinion formatWritten review

Overview

Prof. Xue-Ning Yang is a senior specialist at the Guangdong Lung Cancer Institute and a renowned advocate for Evidence-Based Medicine (EBM) in China. He possesses profound expertise in surgical treatment and personalized Multidisciplinary Team (MDT) approaches for lung cancer, excelling at translating cutting-edge clinical research into precision treatment plans for patients.

Board Certification
Pulmonary Surgery
Clinical Focus
Early-stage Lung Cancer | Locally Advanced Lung Cancer | Personalized Care
Approach
Guideline-driven + personalized
Best for
New diagnosis · Recurrence · Complex decisions
Clinical focus & conditions

Lung cancer (Non-Small Cell Lung Cancer, Small Cell Lung Cancer, etc.)
pulmonary nodules
pleural tumors
mediastinal tumors

Education & training

MD,Ph.D. — Sun Yat-sen University Cancer Center/Tumor Hospital
Training — Advanced training in Thoracic Surgery at European Institute of Oncology
Training — Thoracic Surgery Fellowship at Istituto Nazionale Tumori, Milan, Italy

Hospital affiliations

Guangdong Provincial People's Hospital

Honors & Research

Honors:
Second Prize of National Science and Technology Progress Award; First Prize of Guangdong Science and Technology Progress Award (multiple); Chinese Medical Science and Technology Award.
Academic Positions:
Deputy Chairman, Lung Cancer Committee of China Anti-Cancer Association (CACA); Council Member, Chinese Society of Clinical Oncology (CSCO); Deputy Chairman, Guangdong Anti-Cancer Association Lung Cancer Committee; Member of International Association for the Study of Lung Cancer (IASLC); Associate Editor of Evidence-Based Medicine journal.
Research:
Led/participated in multiple national projects including 863 Program and National Natural Science Foundation of China. Published 60+ papers in professional journals. Contributed to monographs and guidelines such as Theory and Practice of Multidisciplinary Comprehensive Treatment of Lung Cancer and Chinese Lung Cancer Clinical Guidelines. Key research areas: pulmonary nodule management, molecular classification of lung cancer, targeted therapy, and perioperative management.

Is my case a fit for a second opinion?

A second opinion is often helpful if you have a new diagnosis multiple treatment options discordant pathology or imaging results  progression/recurrence or you want confirmation before starting therapy.
•Good fit: complex decisions uncertainty multiple lines of therapy clinical trial questions.
•Not a fit: emergencies (e.g. severe symptoms acute complications). Seek urgent local care.

Important note

This page is for educational and second-opinion purposes. It is not a substitute for emergency care or an in-person exam. If you have urgent symptoms, contact local emergency services.